Cheng Yi Pharmaceuticals Joins Hands with McKinsey Pharmaceuticals

On the afternoon of June 16th, Zhao Chunjian, General Manager of Cheng Yi Pharmaceutical, and Ma Yunpeng, General Manager of McKen Pharmaceutical (Dalian) Co., Ltd., signed a "Medium and Long Term Marketing Strategic Cooperation Agreement for Glucosamine Hydrochloride Capsules (hereinafter referred to as Aminoglucose) in Dongtou, Wenzhou. Both parties plan to comprehensively expand the sales of ammonia sugar capsules in the national terminal market through strategic cooperation, complementary advantages, product promotion, and brand promotion. The agreement stipulates that within the next ten years, the sales volume of some products of Cheng Yi Pharmaceutical's ammonia sugar capsules will reach over 5 billion capsules, and the company will build a leading brand in the ammonia sugar OTC (over-the-counter drug) category market over a period of three to five years.

▲Ma Yunpeng, General Manager of McKinsey Pharmaceutical (left), and Zhao Chunjian, General Manager of Cheng Yi Pharmaceutical, attended the signing ceremony.

▲From left: Huang Chenhan and Liu Yang from McKinsey Pharmaceutical, Li Shisheng and Zhao Chunjian from Cheng Yi Pharmaceutical, Ma Yunpeng from McKinsey Pharmaceutical, Luo Feiyue and Na Hong from Cheng Yi Pharmaceutical.

McKen Pharmaceutical (Dalian) Co., Ltd. was established in 1993 and is headquartered in Dalian. Currently, it has over 800 sales management and marketing personnel, with an annual sales revenue of over 500 million yuan. It has specialized sales branches and nearly 500 OTC market business, marketing, and training teams in Liaoning, Heilongjiang, Henan, Shandong, Shaanxi, and Chongqing provinces, and has a complete distribution and retail network. Brand operation, market promotion, and sales management are the advantages of the company. McKen Pharmaceuticals has established stable cooperative relationships with over 25 provinces and cities across the country, over 100 mainstream pharmaceutical commercial wholesale enterprises, top 100 chain stores nationwide, and over 300000 retail terminals of pharmacies. Its responsible brands such as "Bufei Wan" and "Shujin Jianyao Wan" have established themselves in the national market.

At present, Cheng Yi Pharmaceutical's hydrochloric acid glucosamine capsule products have unique advantages such as full industry chain, full specifications, high purity, and no excipients, making them the largest sales volume of similar products in China. At the signing ceremony, Mr. Ma Yunpeng, General Manager of McKinsey Pharmaceutical (Dalian) Co., Ltd., expressed confidence and determination to further promote Cheng Yi Pharmaceutical Hydrochloric Glucosamine Capsules to the national market, strengthen and expand, and establish the brand through advertising and brand marketing models.